| Abbreviations | Name |
| ACEIs | Angiotensin-converting enzyme inhibitors |
| AGEs | Advanced glycation end products |
| ALB | Albiflorin |
| AMY | Amygdalin |
| Ang II | Angiotensin II |
| APD | Action potential duration |
| ARBs | Angiotensin receptor blockers |
| AREs | Antioxidant response elements |
| AS | Atherosclerosis |
| CHD | Coronary heart disease |
| CPBEB | Core set for the promotion of blood circulation and the elimination of blood stasis |
| CPT1 | Carnitine palmitoyltransferase 1 |
| CRQRP | Core set for the regulation of qi and the relief of pain |
| CVDs | Cardiovascular diseases |
| EndMT | Endothelial–mesenchymal transition |
| ER | Endoplasmic reticulum |
| ERβ | Estrogen receptor β |
| ET-1 | Endothelin-1 |
| FA | Ferulic acid |
| FASN | Fatty acid synthase |
| FFAs | Free fatty acids |
| FNT | Formononetin |
| FXR | Farnesoid X receptor |
| Gas6 | Growth arrest-specific protein 6 |
| GIP | Glucose-dependent insulinotropic polypeptide |
| GM | Gut microbiota |
| GRo | Ginsenoside Ro |
| GSDMD | Gasdermin D |
| HATs | Histone acetyltransferases |
| HCAECs | Human coronary artery endothelial cells |
| Hcy | Homocysteine |
| HDACs | Histone deacetylases |
| HFD | High-fat diet |
| HK1 | Hexokinase 1 |
| HSD | Hesperidin |
| HSYA | Hydroxysafflor yellow A |
| I/R | Ischemia–reperfusion |
| ICAM-1 | Intercellular adhesion molecule-1 |
| ISL | Isoliquiritigenin |
| LIQ | Liquiritin |
| lncRNA | Long noncoding RNA |
| LPS | Lipopolysaccharide |
| LTG | Liquiritigenin |
| MAFLD | Metabolic dysfunction-associated fatty liver disease |
| MDH1 | Malate dehydrogenase 1 |
| MHC II | Major histocompatibility complex class II |
| MI | Myocardial infarction |
| MMPs | Matrix metalloproteinases |
| MPO | Myeloperoxidase |
| MPT | Mitochondrial permeability transition |
| mPTP | Mitochondrial permeability transition pore |
| NAR | Naringin |
| NETs | Neutrophil extracellular traps |
| NHP | Neohesperidin |
| NOB | Nobiletin |
| NR | Narirutin |
| NRG | Naringenin |
| ox-LDL | Oxidized low-density lipoprotein |
| PAF | Platelet-activating factor |
| p-ASK1 | Phosphorylated apoptosis signal-regulating kinase 1 |
| PD | Platycodin D |
| PDGF | Platelet-derived growth factor |
| PDI | Protein disulfide isomerase |
| PF | Paeoniflorin |
| PKA | Protein kinase A |
| PKC | Protein kinase C |
| PLCγ2 | Phospholipase Cγ2 |
| PYGL | Glycogen phosphorylase L |
| RAAS | Renin–angiotensin–aldosterone system |
| ROF | Rhoifolin |
| ROS | Reactive oxygen species |
| SCFAs | Short-chain fatty acids |
| SOCE | Store-operated calcium entry |
| SphK1/2 | Sphingosine kinases 1/2 |
| SR | Sarcoplasmic reticulum |
| SR-A | Scavenger receptor-A |
| SSa | Saikosaponin A |
| TCM | Traditional Chinese medicine |
| Th1 | T helper 1 |
| TLRs | Toll-like receptors |
| TMA | Trimethylamine |
| TMAO | Trimethylamine N-oxide |
| VCAM-1 | Vascular cell adhesion molecule-1 |
| VEGF | Vascular endothelial growth factor |
| VLDL | Very-low-density lipoprotein |
| VSMCs | Vascular smooth muscle cells |
| vWF | von Willebrand factor |
| XFZYD | Xuefu Zhuyu Decoction |
| β-ECD | β-ecdysterone |